Xiaole Shirley Liu

28PUBLICATIONS
214CO-AUTHORS
Innate immunityHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 24, 2026
Tumor γδ T-cell abundance is associated with favorable cancer treatment outcomes.

|Dec 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.

Julia Paczkowska, Ming Tang, Kyle T Wright

|Sep 01, 2024
Robust identification of perturbed cell types in single-cell RNA-seq data.

Phillip B Nicol, Danielle Paulson, Gege Qian

|Feb 22, 2023
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines.

Yoshinaga Ito, Deng Pan, Wubing Zhang

|Feb 06, 2023
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.

Avinash Sahu, Xiaoman Wang, Phillip Munson

|Oct 20, 2022
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition.

Yadira M Soto-Feliciano, Francisco J Sánchez-Rivera, Florian Perner

Pageof 5

Frequent Collaborators

7 joint publications

Myles Brown

5 joint publications

Henry W Long

4 joint publications

Xintao Qiu

4 joint publications

Bo Li